The HIV (1+2) Antibody Rapid Test by NEWSCEN (NewScen Coast Bio-Pharmaceutical Co., Ltd.) is expected to obtain the IVDR CE certification (Regulation EU 2017/746) officially in Q3 of 2025, issued by TÜV SÜD Product Service GmbH, a globally renowned third-party endorsement organization of the EU, in accordance with IVDR regulations. It would be a significant milestone for NEWSCEN’s internationalization...